10 20 30 40 50 60 70 80 1YZ4 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HYDROLASE 28-FEB-05 1YZ4
TITLE CRYSTAL STRUCTURE OF DUSP15
COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PHOSPHATASE-LIKE 15 ISOFORM A; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN; COMPND 5 SYNONYM: DUSP15; COMPND 6 EC: 3.1.3.48; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28A
KEYWDS HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR S.J.KIM,S.E.RYU,D.G.JEONG,T.S.YOON,J.H.KIM,Y.H.CHO, AUTHOR 2 S.K.JEONG,J.W.LEE,J.H.SON
REVDAT 2 24-FEB-09 1YZ4 1 VERSN REVDAT 1 01-NOV-05 1YZ4 0
JRNL AUTH T.S.YOON,D.G.JEONG,J.H.KIM,Y.H.CHO,J.H.SON,J.W.LEE, JRNL AUTH 2 S.E.RYU,S.J.KIM JRNL TITL CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JRNL TITL 2 VHY, A DUAL-SPECIFICITY PROTEIN PHOSPHATASE JRNL REF PROTEINS V. 61 694 2005 JRNL REFN ISSN 0887-3585 JRNL PMID 16170801 JRNL DOI 10.1002/PROT.20642
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 13673 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 701 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2483 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 94 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.29 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.77 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1YZ4 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 02-MAR-05. REMARK 100 THE RCSB ID CODE IS RCSB032093.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-APR-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13673 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE, PEG 8000, BETA- REMARK 280 OCTYL GLUCOPYRANOSIDE, PH 7.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.61650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.71450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.19750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 50.71450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.61650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.19750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 157 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 1 78.89 -64.42 REMARK 500 ARG A 122 78.37 -178.35 REMARK 500 ASN A 126 92.41 -167.75 REMARK 500 ALA A 141 -76.34 -83.26 REMARK 500 ASN B 3 52.47 -68.72 REMARK 500 PRO B 43 98.27 -69.05 REMARK 500 PRO B 54 85.37 -69.33 REMARK 500 ASP B 57 78.61 -113.83 REMARK 500 PRO B 59 -1.19 -59.10 REMARK 500 SER B 93 -69.03 -104.45 REMARK 500 ASN B 126 94.45 -173.26 REMARK 500 ALA B 141 -46.37 -134.24 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BOG A 210 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 211 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 158 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 159 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 160
DBREF 1YZ4 A 1 157 UNP Q5QP65 Q5QP65_HUMAN 1 157 DBREF 1YZ4 B 1 157 UNP Q5QP65 Q5QP65_HUMAN 1 157
SEQADV 1YZ4 GLY A -2 UNP Q5QP65 CLONING ARTIFACT SEQADV 1YZ4 SER A -1 UNP Q5QP65 CLONING ARTIFACT SEQADV 1YZ4 HIS A 0 UNP Q5QP65 CLONING ARTIFACT SEQADV 1YZ4 SER A 88 UNP Q5QP65 CYS 88 ENGINEERED SEQADV 1YZ4 GLY B -2 UNP Q5QP65 CLONING ARTIFACT SEQADV 1YZ4 SER B -1 UNP Q5QP65 CLONING ARTIFACT SEQADV 1YZ4 HIS B 0 UNP Q5QP65 CLONING ARTIFACT SEQADV 1YZ4 SER B 88 UNP Q5QP65 CYS 88 ENGINEERED
SEQRES 1 A 160 GLY SER HIS MET GLY ASN GLY MET THR LYS VAL LEU PRO SEQRES 2 A 160 GLY LEU TYR LEU GLY ASN PHE ILE ASP ALA LYS ASP LEU SEQRES 3 A 160 ASP GLN LEU GLY ARG ASN LYS ILE THR HIS ILE ILE SER SEQRES 4 A 160 ILE HIS GLU SER PRO GLN PRO LEU LEU GLN ASP ILE THR SEQRES 5 A 160 TYR LEU ARG ILE PRO VAL ALA ASP THR PRO GLU VAL PRO SEQRES 6 A 160 ILE LYS LYS HIS PHE LYS GLU CYS ILE ASN PHE ILE HIS SEQRES 7 A 160 CYS CYS ARG LEU ASN GLY GLY ASN CYS LEU VAL HIS SER SEQRES 8 A 160 PHE ALA GLY ILE SER ARG SER THR THR ILE VAL THR ALA SEQRES 9 A 160 TYR VAL MET THR VAL THR GLY LEU GLY TRP ARG ASP VAL SEQRES 10 A 160 LEU GLU ALA ILE LYS ALA THR ARG PRO ILE ALA ASN PRO SEQRES 11 A 160 ASN PRO GLY PHE ARG GLN GLN LEU GLU GLU PHE GLY TRP SEQRES 12 A 160 ALA SER SER GLN LYS LEU ARG ARG GLN LEU GLU GLU ARG SEQRES 13 A 160 PHE GLY GLU SER SEQRES 1 B 160 GLY SER HIS MET GLY ASN GLY MET THR LYS VAL LEU PRO SEQRES 2 B 160 GLY LEU TYR LEU GLY ASN PHE ILE ASP ALA LYS ASP LEU SEQRES 3 B 160 ASP GLN LEU GLY ARG ASN LYS ILE THR HIS ILE ILE SER SEQRES 4 B 160 ILE HIS GLU SER PRO GLN PRO LEU LEU GLN ASP ILE THR SEQRES 5 B 160 TYR LEU ARG ILE PRO VAL ALA ASP THR PRO GLU VAL PRO SEQRES 6 B 160 ILE LYS LYS HIS PHE LYS GLU CYS ILE ASN PHE ILE HIS SEQRES 7 B 160 CYS CYS ARG LEU ASN GLY GLY ASN CYS LEU VAL HIS SER SEQRES 8 B 160 PHE ALA GLY ILE SER ARG SER THR THR ILE VAL THR ALA SEQRES 9 B 160 TYR VAL MET THR VAL THR GLY LEU GLY TRP ARG ASP VAL SEQRES 10 B 160 LEU GLU ALA ILE LYS ALA THR ARG PRO ILE ALA ASN PRO SEQRES 11 B 160 ASN PRO GLY PHE ARG GLN GLN LEU GLU GLU PHE GLY TRP SEQRES 12 B 160 ALA SER SER GLN LYS LEU ARG ARG GLN LEU GLU GLU ARG SEQRES 13 B 160 PHE GLY GLU SER
HET BOG A 210 20 HET SO4 A 211 5 HET SO4 B 158 5 HET SO4 B 159 5 HET SO4 B 160 5
HETNAM BOG B-OCTYLGLUCOSIDE HETNAM SO4 SULFATE ION
FORMUL 3 BOG C14 H28 O6 FORMUL 4 SO4 4(O4 S 2-) FORMUL 8 HOH *94(H2 O)
HELIX 1 1 ILE A 18 LYS A 21 5 4 HELIX 2 2 ASP A 22 ASN A 29 1 8 HELIX 3 3 PRO A 62 LYS A 65 5 4 HELIX 4 4 HIS A 66 ASN A 80 1 15 HELIX 5 5 SER A 93 GLY A 108 1 16 HELIX 6 6 GLY A 110 THR A 121 1 12 HELIX 7 7 ASN A 128 ALA A 141 1 14 HELIX 8 8 ALA A 141 GLY A 155 1 15 HELIX 9 9 ASN B 16 ASP B 22 1 7 HELIX 10 10 ASP B 22 ASN B 29 1 8 HELIX 11 11 PRO B 62 LYS B 65 5 4 HELIX 12 12 HIS B 66 ASN B 80 1 15 HELIX 13 13 SER B 93 GLY B 108 1 16 HELIX 14 14 GLY B 110 ARG B 122 1 13 HELIX 15 15 ASN B 128 GLY B 139 1 12 HELIX 16 16 ALA B 141 PHE B 154 1 14
SHEET 1 A 5 THR A 6 LEU A 9 0 SHEET 2 A 5 LEU A 12 GLY A 15 -1 O LEU A 12 N LEU A 9 SHEET 3 A 5 CYS A 84 SER A 88 1 O VAL A 86 N TYR A 13 SHEET 4 A 5 HIS A 33 ILE A 37 1 N HIS A 33 O LEU A 85 SHEET 5 A 5 THR A 49 ILE A 53 1 O ILE A 53 N SER A 36 SHEET 1 B 5 THR B 6 LEU B 9 0 SHEET 2 B 5 LEU B 12 GLY B 15 -1 O LEU B 12 N VAL B 8 SHEET 3 B 5 CYS B 84 HIS B 87 1 O VAL B 86 N TYR B 13 SHEET 4 B 5 HIS B 33 SER B 36 1 N HIS B 33 O LEU B 85 SHEET 5 B 5 THR B 49 ARG B 52 1 O THR B 49 N ILE B 34
SITE 1 AC1 9 HIS A 38 GLU A 39 PHE A 89 ARG A 94 SITE 2 AC1 9 HOH A 218 VAL B 8 LEU B 9 VAL B 103 SITE 3 AC1 9 ALA B 117 SITE 1 AC2 9 SER A 88 PHE A 89 ALA A 90 GLY A 91 SITE 2 AC2 9 ILE A 92 SER A 93 ARG A 94 HOH A 215 SITE 3 AC2 9 HOH A 218 SITE 1 AC3 7 SER B 88 PHE B 89 ALA B 90 GLY B 91 SITE 2 AC3 7 ILE B 92 SER B 93 ARG B 94 SITE 1 AC4 5 ARG A 52 ARG A 112 GLY B 155 GLU B 156 SITE 2 AC4 5 SER B 157 SITE 1 AC5 4 HIS B 38 GLU B 39 SER B 40 ARG B 94
CRYST1 43.233 76.395 101.429 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.023130 0.000000 0.000000 0.00000
SCALE2 0.000000 0.013090 0.000000 0.00000
SCALE3 0.000000 0.000000 0.009859 0.00000